Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guerin: Implications for Clinical Trial Design EDITORIAL COMMENTS

被引：0
|
作者：
Matulewicz, Richard S. [1 ]
Steinberg, Gary D. [1 ]
机构：
[1] NYU, Dept Urol, Langone Hlth, New York, NY 10003 USA
来源：
JOURNAL OF UROLOGY | 2021年 / 205卷 / 06期
关键词：
D O I：
10.1097/JU.0000000000001633.01
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1619 / 1620
页数：2
相关论文
共 50 条
  • [41] Association of Polymorphisms in Oxidative Stress Genes with Clinical Outcomes for Bladder Cancer Treated with Bacillus Calmette-Guerin
    Wei, Hua
    Kamat, Ashish
    Chen, Meng
    Ke, Hung-Lung
    Chang, David W.
    Yin, Jikai
    Grossman, H. Barton
    Dinney, Colin P.
    Wu, Xifeng
    [J]. PLOS ONE, 2012, 7 (06):
  • [42] A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer.
    Escano, De Jesus Manuel R.
    Sjoberg, Daniel D.
    McCarter, Melissa
    McGill, Marlena
    Goh, Alvin
    Donahue, Timothy F.
    Donat, Machele S.
    Cha, Eugene K.
    Herr, Harry W.
    Meraney, Anoop M.
    Al-Ahmadie, Hikmat A.
    Solit, David B.
    Dalbagni, Guido
    Bajorin, Dean F.
    Bochner, Bernard H.
    Pietzak, Eugene J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [43] ELUCIDATING THE RESPONSE RATES TO CONTINUED BACILLUS CALMETTE-GUERIN (BCG) IN PATIENTS WITH BCG EXPOSED BLADDER CANCER: IMPLICATIONS FOR CLINICAL TRIAL DESIGN
    Myers, Amanda A.
    Tan, Wei Shen
    Grajales, Valentina
    Hwang, Hyunsoo
    Bree, Kelly K.
    Navai, Neema
    Lee, Byron H.
    Dinney, Colin P. N.
    Kamat, Ashish M.
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E627 - E627
  • [44] Intravesical Bacillus Calmette-Guerin Outcomes in Patients With Bladder Cancer and Asymptomatic Bacteriuria
    Herr, Harry W.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (02): : 435 - 437
  • [45] Impact of UTUC on Outcomes of Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Bree, K. K.
    Hensley, P. J.
    Brooks, N.
    Matulay, J.
    Navai, N.
    Grossman, H. B.
    Matin, S. F.
    Dinney, C. P.
    Kamat, A. M.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 898 - 898
  • [46] The Challenge of Bacillus Calmette-Guerin Failure in Nonmuscle Invasive Bladder Cancer-What is the Next Step in Management?
    Lotan, Yair
    [J]. JOURNAL OF UROLOGY, 2013, 190 (03): : 832 - 833
  • [47] The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guerin therapy
    Savic, Spasenija
    Zlobec, Inti
    Thalmann, George N.
    Engeler, Daniel
    Schmauss, Martina
    Lehmann, Kurt
    Mattarelli, Gianfranco
    Eichenberger, Tobias
    Dalquen, Peter
    Spieler, Peter
    Schoenegg, Rene
    Gasser, Thomas C.
    Sulser, Tullio
    Forster, Thomas
    Zellweger, Tobias
    Casella, Roberto
    Bubendorf, Lukas
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (12) : 2899 - 2904
  • [48] Adding mitomycin to Bacillus Calmette-Guerin as adjuvant intravesical therapy for high-risk, nonmuscle-invasive urothelial bladder cancer (BCGMM; ANZUP 1301)
    Liow, Elizabeth Chien Hern
    Hayne, Dickon
    Stockler, Martin R.
    Martin, Andrew James
    Sengupta, Shomik
    Anderson, Paul
    Ford, Kate
    Frydenberg, Mark
    Gorzeman, Margot
    Green, Will
    Grummet, Jeremy
    Hawks, Cynthia
    Krieger, Laurence Eliot Miles
    Ischia, Joseph
    McCombie, Steve
    Patel, Manish
    Davis, Ian D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [49] Bacillus Calmette-Guerin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma
    Aznar Martinez, Laura
    Lopez Cubillana, Pedro
    Lopez Abadb, Alicia
    Vidal Crespo, Natalia
    Gomez Gomez, Guillermo Antonio
    [J]. UROLOGIA INTERNATIONALIS, 2019, 103 (02) : 242 - 244
  • [50] Cost-Effectiveness of Maintenance bacillus Calmette-Guerin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer
    Sharma, Vidit
    Wymer, Kevin M.
    Borah, Bijan J.
    Saigal, Christopher S.
    Litwin, Mark S.
    Packiam, Vignesh T.
    Thompson, R. Houston
    Tollefson, Matthew K.
    Karnes, R. Jeffrey
    Boorjian, Stephen A.
    [J]. JOURNAL OF UROLOGY, 2020, 204 (03): : 442 - 449
12345